Skip to main content

Product availability

Important update regarding Enterra® Therapy

We would like to share an update regarding Enterra Therapy. The availability of Enterra® II implantable pulse generators (IPGs) is currently limited due to shortages of key components used to manufacture the device, which may affect the scheduling of some procedures. We understand this situation may raise important questions about your treatment, particularly if you are considering Enterra Therapy or are waiting for a procedure.

Enterra Medical is working urgently to address the current supply constraints and support patients and healthcare providers. Our next-generation Enterra Therapy System has been submitted to our European Notified Body for review. While that review is ongoing, we do not yet have information regarding the timing or availability of the next-generation system. We will provide updates as information becomes available.

During this period, availability of Enterra Therapy devices may vary by country and treatment centre. Your healthcare provider is the best source of information regarding device availability, procedure scheduling, and appropriate next steps.

What should I do?

If you are considering Enterra Therapy or have a procedure planned, please remain in contact with your healthcare provider. Your healthcare provider is the best source of information regarding your individual treatment plan, procedure scheduling, and any appropriate next steps.

Is Enterra Therapy being discontinued?

No. Enterra Therapy is not being discontinued. The current supply constraints are related to the availability of components used to manufacture the device.

Stay updated

We will continue to share updates on this page as additional information becomes available.

For questions about your individual care, treatment plan, or procedure scheduling, please contact your healthcare provider.

A message to patients and caregivers

We recognise that this situation may create uncertainty for patients and families. We sincerely appreciate your patience and the trust you have placed in Enterra Therapy. Our commitment to supporting patients, caregivers, and healthcare providers remains unchanged, and we will continue to share updates as new information becomes available.

IMPORTANT SAFETY INFORMATION

The Enterra® Therapy System for gastric electrical stimulation (GES) is indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis. This system has not been evaluated for pregnant women, for use in patients under the age of 18, or patients over the age of 70. Patients should always discuss potential risks and benefits with their clinician.